CL2007003675A1 - Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimie - Google Patents
Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimieInfo
- Publication number
- CL2007003675A1 CL2007003675A1 CL200703675A CL2007003675A CL2007003675A1 CL 2007003675 A1 CL2007003675 A1 CL 2007003675A1 CL 200703675 A CL200703675 A CL 200703675A CL 2007003675 A CL2007003675 A CL 2007003675A CL 2007003675 A1 CL2007003675 A1 CL 2007003675A1
- Authority
- CL
- Chile
- Prior art keywords
- agent
- controlled liberation
- antiglucemian
- bioadherent
- nucleus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0605967-8A BRPI0605967A (pt) | 2006-12-20 | 2006-12-20 | composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007003675A1 true CL2007003675A1 (es) | 2008-06-27 |
Family
ID=39536766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200703675A CL2007003675A1 (es) | 2006-12-20 | 2007-12-18 | Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimie |
Country Status (3)
Country | Link |
---|---|
BR (1) | BRPI0605967A (pt) |
CL (1) | CL2007003675A1 (pt) |
WO (1) | WO2008074108A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011111068A2 (en) | 2010-03-09 | 2011-09-15 | Council Of Scientific And Industrial Research | Gastroretentive, extended release composition of therapeutic agent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN192180B (pt) * | 2001-09-28 | 2004-03-06 | Ranbaxy Lab | |
US20030187074A1 (en) * | 2002-03-04 | 2003-10-02 | Javed Hussain | Oral compositions for treatment of diabetes |
WO2005092293A1 (en) * | 2004-03-22 | 2005-10-06 | Ranbaxy Laboratories Limited | Formulations of metformin |
-
2006
- 2006-12-20 BR BRPI0605967-8A patent/BRPI0605967A/pt not_active IP Right Cessation
-
2007
- 2007-12-05 WO PCT/BR2007/000331 patent/WO2008074108A2/en active Application Filing
- 2007-12-18 CL CL200703675A patent/CL2007003675A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008074108A2 (en) | 2008-06-26 |
BRPI0605967A (pt) | 2008-08-12 |
WO2008074108A3 (en) | 2008-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP10010533A (es) | Derivados de 4-aminociclohexano sustituido | |
CY1117143T1 (el) | Νεα καρβονυλιωμενα (αζα)κυκλοεξανια ως προσδετες του d3 υποδοχεα ντοπαμινης | |
CO6361937A2 (es) | Derivados de heteroaril amidas y sus usos como activadores de glucoquinasa | |
BRPI0908208A2 (pt) | Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto. | |
BRPI0718782A2 (pt) | Agente de benefício que contém partícula de liberação | |
ECSP11010529A (es) | Derivados de ciclohexano espirociclicos sustituidos | |
CL2007002851A1 (es) | Composicion inyectable que comprende micro o nano -particulas biodegradables que incluyen un agente activo, un polimero biodegardable, un agente para intensificar la viscosidad y excipiente farmaceuticamente aceptables; y procedimientos de preparacion | |
DOP2011000173A (es) | Compuestos organico | |
BRPI0812807A2 (pt) | Método para a produção de um medicamento que contem tadafila | |
BRPI0921269A2 (pt) | combinação de um oxidante e um fotoativador para a cura de ferimentos | |
CL2008001896A1 (es) | 3-dihalometil-1-metil-1h-pirazol-4-carbaldehidos; su proceso de preparacion usando un intermediario de hidrazona, que reacciona con un agente de vilsmeier; y el derivado de hidrazona usado. | |
CL2007002121A1 (es) | Compuestos derivados de pirazoles, activadores de glucoquinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que comprende dichos compuestos; y uso para el tratamiento de enfermedades y/o trastornos metabolicos, tal como diab | |
CL2010001428A1 (es) | Compuestos derivados de amidas y tioamidas heteroaromaticas; agente que contiene al menos uno de dichos compuestos; procedimiento para combatir parasitos; y uso de dichos compuestos. | |
ECSP11011183A (es) | Compuestos orgánicos | |
CL2009000639A1 (es) | Pirimidinas-5-acarboxamidas sustituidas; la composicion farmceutica que la contiene; y sus usos. | |
DK2282994T3 (da) | 3-aminocarbazolforbindelse, farmaceutisk sammensætning indeholdende forbindelsen samt fremstillingsmetode derfor | |
WO2011018583A3 (fr) | Nouvelles formulations pharmaceutiques contre le mésusage des médicaments | |
CL2007003201A1 (es) | Composicion farmaceutica liquida que comprende un derivado de ciclodextrina eterificada y un bencimidazol sustituido, donde el derivado de ciclodextrina se selecciona de eter de alfa, beta y gama-ciclodextrina; y uso para el tratamiento de insuficien | |
PE20130701A1 (es) | Composicion de pigmentos solubles en agua o en solventes organicos | |
CR10665A (es) | Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR064955A1 (es) | Composicion y metodo para estabilizar ingredientes sensibles | |
WO2011089595A3 (en) | Sustained-release nucleic acid matrix compositions | |
UY30330A1 (es) | Nuevas formas polimorfas de (2s)-(4e)-n-metil-5-(3-(5-isopropoxipiridin)il)-4-penten-2-amina | |
BRPI0922341A2 (pt) | composição farmacêutica revestida em fusão com liberação rápida. | |
DK2120585T3 (da) | Langtidsfrigivet farmaceutisk sammensætning indeholdende vandig opløsning af bisfosfonat |